首页> 外国专利> Spiro oxindole compounds - that is, a Pharmaceutical Composition and its use for the treatment of diseases or conditions mediated by the sodium channels.

Spiro oxindole compounds - that is, a Pharmaceutical Composition and its use for the treatment of diseases or conditions mediated by the sodium channels.

机译:螺羟吲哚化合物-即药物组合物及其在钠通道介导的疾病或病症的治疗中的用途。

摘要

1. Formula (1) using spiro oxygenates: where j, K, m, Q, x, cyclic a, R1, R2A r2b, r2c, r2d and R3 have defined values, i.e. stereoisomer, coaxial dwarf or coaxial variant; or acceptable pharmaceutical salt, N-oxide salt, solvato salt or their biological products, Used to treat and / or prevent diseases or conditions, such as pain, that are transmitted through the sodium channel. Item 1: a compound whose characteristic is its response formula (1), in which J and K are independent of 0, 1, 2 or 3; m is 0, 1, 2 or 4; X is o or s; ring a is a fused heterocyclic ring or a fused heterocyclic ring;Q is - C (R1a) 2-- that is...-S (o) P - (P is 0, 1, 2),-CF2, -OC (O) -,-That's it.-C (O) N (R5) --N (R5) - o -N (R5) C (O) -Each R1a is h-or5, or two R1a, plus the related carbon, to form an oxo group; R1 is hydrogen, tar, amino, asphalt, halo tar, arilo, cyclopropyl, cyclopropene, isopropene, isopropene, r8-c (o) R5, r8-c (o) n (R4) R5, s (o) t-r5 (T1 or R2),-R9-s (o) p-r5 (P is 0, 1 or 2),-Lulululu, Aoji Union, Zhihuan Sansan, non Huanhuan Huanhuan 444, Huanhuan 444, Huanhuan 4, 5, 5, 5, 5, 5, arilo, Zhili, or R6, R7, In addition to the nitroglycerin attached to them, they form an isomerization or isomerization isomerization, in which each group of arillo, allokiro, cyclopentadiene, cyclopentadiene, isopropene, isopropene,heteroaryl and heteroaryl for R6 and R7 may optionally be substituted with one or more substituents selected from the group consisting of alkyl, cycloalkyl, aryl, aralkyl, halo, haloalkyl, -R8-CN, -R8-OR5, heterocyclyl and heteroaryl; or R1 is aralkyl optionally substituted with one or more substituents selected from the group consisting of -R8-OR5, -C (O) OR5, halo, haloalkyl, alkyl, nitro, cyano, aryl, aralkyl, heterocyclyl and heteroaryl; or R1 is -R9-N (R10) R11, -R9- N (R12) C (O) R11 or -R9-C (O) N (R12) R11 or -R9-N (R10) C (O) N (R10) R11 where: each R10 is hydrogen, alkyl, aryl, aralkyl or heteroaryl; Each R11 is hydrogen, alkyl, haloalkyl, cycloalkyl,cycloalkylalkyl, aryl, aralkyl, heterocyclyl, heterocyclylalkyl, heteroaryl, heteroarylalkyl, -R9-OC (O) R5, -R9-C (O) OR5, -R9-C (O) N (R4) R5, -R9-C ( O) R5, -R9-N (R4) R5, -R9-OR5, or -R9-CN; R12 is hydrogen, alkyl, aryl, aralkyl or -C (O) R5; and wherein each aryl, aralkyl, cycloalkyl, cycloalkylalkyl, heterocyclyl, heterocyclylalkyl, heteroaryl and heteroarylalkyl group for R10 and R11 may optionally be substituted with one or more substituents selected from the group consisting of alkyl, cycloalkyl, aryl, aralkyl, halo, haloalkyl, nitro, -R8-CN, -R8-OR5, -R8-C (O) R5, heterocyclyl and heteroaryl;or R1 is heterocyclylalkyl or heteroarylalkyl where the heterocyclylalkyl or heteroarylalkyl group is optionally substituted by one or more substituents selected from the group consisting of alkyl, halo, haloalkyl, -R8-OR5, -R8-C (O) OR5, aryl and aralkyl ; R2a, R2b, R2c and R2d are each independently selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, halo, haloalkyl, haloalkenyl, cycloalkyl, cycloalkylalkyl, aryl, aralkyl, aralkenyl, heterocyclyl, heterocyclylalkyl, heteroaryl, heteroarylalkyl, -R8-CN, -R8-NO2, -R8-OR5, -R8-N (R4) R5, -R8-N = C (R4) R5, -R8-S (O) pR4, -R8- OS (O) 2CF3, -R8-C (O) R4, -R8-C (S) R4,-R8-C (O) OR4, -R8-C (S) OR4, -R8-C (O) N (R4) R5, -R8-C (S) N (R4) R5, -R8-N (R5 ) C (O) R4, -R8-N (R5) C (S) R4, -R8-N (R5) C (O) OR4, -R8-N (R5) C (S) OR4, -R8-N (R5) C (O) N (R4) R5, -R8-N (R5) C (S) N (R4) R5, -R8-N (R5) S (O) tR4, -R8-N (R5) S (O) t (R4) R5, - R8-S (O) tN (R4) R5, -R8-N (R5) C (= NR5) N (R4) R5, and -R8-N (R5) C (= N-CN) N (R4) R5, where each p is independently 0, 1, or 2 and each t is independently 1 or 2; and wherein each of the cycloalkyl, cycloalkylalkyl, aryl, aralkyl, aralkenyl, heterocyclyl, heterocyclylalkyl, heteroaryl and heteroarylalkyl groups for R2a, R2b, R2c and R2d may optionally be substituted with one or more substituents selected from the group consisting of alkyl alkenylalkynyl, alkoxy, halo, haloalkyl, haloalkenyl, haloalkoxy, cycloalkyl, cycloalkylalkyl, aryl, aralkyl, aralkenyl, heterocyclyl, heterocyclylalkyl, heteroaryl, heteroarylalkyl, -R8-CN, -R8-N (O) 2, -R8 -5, R8-N (R4) R5, -S (O) pR4, -R8-C (O) R4, -R8-C (O) OR4, -R8-C (O) N (R4) R5, -N (R5 ) C (O) R4, and -N (R5) S (O) tR4, where each p is independently 0, 1, or 2 and each t is independently 1 or 2; or R2a and R2b, together with the ring carbon atoms to which they are directly attached, can form a fused ring selected from cycloalkyl, aryl, heterocyclyl and heteroaryl, and R2c and R2d are as defined; or R2b and R2c,Together with the ring carbon atoms directly connected together, they can form a combined ring selected from cyclopentadiene, arilo, isopropene and isopropene, as well as between R2A and r2d; or r2c and r2d, together with the ring carbon atoms directly connected together, A selected combined ring can be formed between cyclopentadiene, arilo, isoacrylonitrile and isopropene and R2A and r2b; each R3 can be selected separately from a group consisting of asphalt, almond, asphalt, halogen, halogen, halogen, halogen, cyclopentadiene, cyclopentadienyl, arilo, aralquilo and aralquenilo, cumene) R5, -And there is one or one or one independent process or one independent process to obtain one or one or one or one independent aralquilo, aralquenilo, heterosexual, heterosexual in one or one or one independent way,The heterogenous and heteromorphic acrylonitrile of R3 can be replaced by one or more substitutes, such as coagulation, halogen, asphalt, tar, propoxy, halogen, halogen, epoxy, cyclopentyl, cyclopentadienyl propenyl, arilo, aralquilo, aralquenilo, isopropene, isopropenylpropenyl, isopropenylpropenyl, isopropylpropenyl, isopropylallyl, isopropylallyl One kind of water resource composition; each kind of independent R2 composition; each kind of different R5, from which one kind of independent flow of water resource is selected; each kind; each kind; each kind; each kind of water anyone, anything,1. Pitch, halogen, halogen, acylhaloglyl propylene, propoxy, cyclopentadiene, cyclopentadienyl allyl, arilo, aralquilo, isopropyl, isopropyl propylene, isopropyl allyl and isopropyl allyl; or when R4 and R5 are combined with the same nitrobenzene atom respectively, R4 and R5 are combined with the attached nitrobenzene atom; They can form an isomerization or isomerization; and each R8 is in a direct link or a linear or branched asphalt chain, or in a linear or branched asphalt chain, or in a linear or branched asphalt chain; and each R9 is a linear or branched asphalt chain, Linear or branched star chains or linear or branched tar chains; as stereoisomers,2. Enantiomero, tautomero or a mixture of both; or acceptable salt for pharmaceutical, N-oxidation, dissolution or production;
机译:1.使用螺状含氧化合物的式(1):其中j,K,m,Q,x,环状a,R 1,R 2A,r 2b,r 2c,r 2d和R 3具有确定的值,即立体异构体,同轴矮级或同轴变体;或可接受的药用盐,N-氧化物盐,溶剂化物盐或其生物制品,用于治疗和/或预防通过钠通道传播的疾病或状况,例如疼痛。第1项:特征在于其响应式(1)的化合物,其中J和K独立于0、1、2或3; m为0、1、2或4; X是o或s;环a为稠合杂环或稠合杂环; Q为-C(R1a)2--即...- S(o)P-(P为0,1,2),-CF2,-OC (O)-,-就是这样-C(O)N(R5)--N(R5)-o -N(R5)C(O)-每个R1a是h-or5或两个R1a,加上碳,形成一个氧代基团; R1是氢,焦油,氨基,沥青,卤代焦油,芳基,环丙基,环丙烯,异丙烯,异丙烯,r8-c(o)R5,r8-c(o)n(R4)R5,s(o)t-r5 (T1或R2),-R9-s(o)p-r5(P为0、1或2),-Lulululu,Aoji Union,Zhihuan Sansan,非欢欢欢欢444,欢欢444,欢欢4,5,5, 5、5、5,arilo,Zhili或R6,R7,除了与它们连接的硝酸甘油外,还形成异构化或异构化异构化,其中每个基团分别是Arillo,Allokiro,环戊二烯,环戊二烯,异丙烯,异丙烯,杂芳基R6和R7的杂芳基可以任选地被一个或多个选自烷基,环烷基,芳基,芳烷基,卤代,卤代烷基,-R8-CN,-R8-OR5,杂环基和杂芳基的取代基取代;或R 1是任选被一个或多个选自-R 8 -OR 5,-C(O)OR 5,卤素,卤代烷基,烷基,硝基,氰基,芳基,芳烷基,杂环基和杂芳基的取代基取代的芳烷基;或或R1为-R9-N(R10)R11,-R9- N(R12)C(O)R11或-R9-C(O)N(R12)R11或-R9-N(R10)C(O)N (R10)R11其中:每个R10为氢,烷基,芳基,芳烷基或杂芳基;每个R 11为氢,烷基,卤代烷基,环烷基,环烷基烷基,芳基,芳烷基,杂环基,杂环基烷基,杂芳基,杂芳基烷基,-R 9 -OC(O)R 5,-R 9 -C(O)OR 5,-R 9 -C(O) N(R4)R5,-R9-C(O)R5,-R9-N(R4)R5,-R9-OR5或-R9-CN; R12是氢,烷基,芳基,芳烷基或-C(O)R5;并且其中R10和R11的每个芳基,芳烷基,环烷基,环烷基烷基,杂环基,杂环基烷基,杂芳基和杂芳基烷基可以任选地被一个或多个选自烷基,环烷基,芳基,芳烷基,卤素,卤代烷基的取代基取代,硝基,-R 8 -CN,-R 8 -OR 5,-R 8 -C(O)R 5,杂环基和杂芳基;或R 1是杂环基烷基或杂芳基烷基,其中杂环基烷基或杂芳基烷基被一个或多个选自以下的取代基取代:烷基,卤代,卤代烷基,-R 8 -OR 5,-R 8 -C(O)OR 5,芳基和芳烷基; R 2a,R 2b,R 2c和R 2d各自独立地选自氢,烷基,烯基,炔基,卤代,卤代烷基,卤代烯基,环烷基,环烷基烷基,芳基,芳烷基,芳烯基,杂环基,杂环基烷基,杂芳基,杂芳基烷基,-R8 -CN,-R8-NO2,-R8-OR5,-R8-N(R4)R5,-R8-N = C(R4)R5,-R8-S(O)pR4,-R8- OS(O)2CF3 ,-R8-C(O)R4,-R8-C(S)R4,-R8-C(O)OR4,-R8-C(S)OR4,-R8-C(O)N(R4)R5, -R8-C(S)N(R4)R5,-R8-N(R5)C(O)R4,-R8-N(R5)C(S)R4,-R8-N(R5)C(O) OR4,-R8-N(R5)C(S)OR4,-R8-N(R5)C(O)N(R4)R5,-R8-N(R5)C(S)N(R4)R5,- R8-N(R5)S(O)tR4,-R8-N(R5)S(O)t(R4)R5,-R8-S(O)tN(R4)R5,-R8-N(R5)C (= NR5)N(R4)R5和-R8-N(R5)C(= N-CN)N(R4)R5,其中每个p独立为0、1或2,每个t独立为1或2 ;并且其中R 2a,R 2b,R 2c和R 2d的每个环烷基,环烷基烷基,芳基,芳烷基,芳烯基,杂环基,杂环基烷基,杂芳基和杂芳基烷基可以任选地被一个或多个选自烷基烯基炔基,烷氧基的取代基取代。 ,卤素,卤代烷基,卤代烯基,卤代烷氧基,环烷基,环烷基烷基,芳基,芳烷基,芳烯基,杂环基,杂环基烷基,杂芳基,杂芳基烷基,-R8-CN,-R8-N(O)2,-R8 -5,R8-N( R4)R5,-S(O)pR4,-R8-C(O)R4,-R8-C(O)OR4,-R8-C(O)N(R4)R5,-N(R5)C(O )R4和-N(R5)S(O)tR4,其中每个p独立为0、1或2,每个t独立为1或2; R 2a和R 2b与它们直接连接的环碳原子一起可以形成选自环烷基,芳基,杂环基和杂芳基的稠合环,并且R 2c和R 2d如上所定义。或R 2b和R 2c,与环碳原子直接连接在一起,它们可以形成选自环戊二烯,芳基,异丙基和异丙基以及在R 2A和r 2d之间的结合环;或r2c和r2d,以及直接连接在一起的环碳原子,可以在环戊二烯,芳基之间形成一个选定的结合环,异丙烯腈和异丙烯以及R 2A和r 2b;每个R 3可以选自由沥青,杏仁,沥青,卤素,卤素,卤素,卤素,环戊二烯,环戊二烯基,芳基,阿拉基洛和阿拉基尼洛,枯烯组成的组中的R 5,并且存在一个或一个或一个独立的过程或通过一种或一种独立的方法以一种或一种或一种或一种独立的方式获得一种或一种或一种或多种独立的aralquilo,alalquenilo,异性恋,异性恋,R3的异质和异质丙烯腈可以被一种或多种替代物所取代,例如凝血,卤素,沥青,焦油,丙氧基,卤素,卤素,环氧,环戊基,环戊二烯基丙烯基,arilo,alalquilo,alalquenilo,异丙烯,异丙烯基丙烯基,异丙烯基丙烯基,异丙基丙烯基,异丙基烯丙基,异丙基烯丙基各种独立的R2组成;每种不同的R5,从中选择一种独立的水资源流量;每一种;每一种;每一种;各种水,任何人,任何人,1。沥青,卤素,卤素,酰基卤代丙烯基丙烯,丙氧基,环戊二烯,环戊二烯丙基烯丙基,芳基,芳基喹啉,异丙基,异丙基丙烯,异丙基烯丙基和异丙基烯丙基;当R 4和R 5分别与相同的硝基苯原子结合时,R 4和R 5与连接的硝基苯原子结合。它们可以形成异构化或异构化。每个R 8在直链或直链或支链的沥青链中,或在直链或支链的沥青链中,或在直链或支链的沥青链中; R9为直链或支链的沥青链,直链或支链的星链或直链或支链的焦油链;作为立体异构体2。对映异构体,互变异构体或两者的混合物;或用于药物,N氧化,溶解或生产的可接受的盐;

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号